Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CSIQ | FSLR |
|---|---|---|
| Price | $11.17 | $179.03 |
| Change today | ▼ 0.71% | ▼ 0.61% |
| Market cap | $758.41M | $19.24B |
| Return, 3 months | -25.5% | -21.6% |
| Return, year to date | -53.0% | -31.5% |
| Return, 1 year | -21.8% | -22.6% |
| P/E (TTM) | -2.9 | 11.0 |
| P/B | 0.3 | 1.9 |
| P/E percentile vs own 5y | 33rd | 5th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -28.7% | -3.7% |
| Net profit growth (YoY) | -291.6% | +23.6% |
| Gross margin | 16.4% | 44.0% |
| Operating margin | -0.6% | 33.6% |
| Net margin | -5.0% | 32.5% |
| Return on equity | -8.9% | 18.5% |
| Analyst target vs. price | +17.3% | +55.2% |
| Analyst buy share | 0% | 80% |
| RSI (14) | 41 | 41 |
| 30-day volatility | 62.6% | 52.2% |
| Max drawdown, 1 year | -69.0% | -45.9% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
